Colorectal Cancer Trial, Recruiting NCT04980287 Sponsor: Jichao Qin Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT04980287
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years
  • People whose overall health has been assessed by an anaesthesiologist and falls within a low-to-moderate risk range (ASA score I to III)
  • People who have had a biopsy that confirmed a diagnosis of colorectal cancer (cancer of the colon or rectum)
  • People whose cancer staging before surgery falls within specific ranges, indicating the cancer has grown into the bowel wall to a certain extent, with or without nearby lymph node involvement, but has not spread to distant parts of the body (confirm with trial site)
  • People whose tumour is located at a specific part of the colon known as the hepatic flexure or the transverse colon near the flexures
  • People who are scheduled to undergo a specific type of surgery to remove the cancer along with surrounding tissue (called complete mesocolic excision with right gastric mesentery resection)
  • People who have been fully informed about the purpose of the trial and have signed a consent form agreeing to take part

Who may not be able to join:

  • People who have more than one colorectal cancer present at the same time
  • People who have signs that their cancer has spread to other parts of the body
  • People who have a previous history of colorectal cancer or any other type of cancer
  • People whose cancer staging falls outside the accepted range for this trial — specifically those with very early-stage or very advanced local disease (confirm with trial site)
  • People who require emergency surgery rather than planned surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 008613628683363

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jichao Qin
Registry
ClinicalTrials.gov
Start date
12 January 2021
Est. completion
19 July 2023

Where this trial is recruiting

🇨🇳 China

Primary endpoints

metastasis rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov